Business Wire

Mary Kay Inc. Names Tara Eustace Chief Opportunity and Sales Officer

Share

To empower future growth, iconic beauty and entrepreneurship company Mary Kay announced today the appointment of Tara Eustace as Chief Opportunity and Sales Officer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250305002799/en/

To empower future growth, iconic beauty and entrepreneurship company Mary Kay announced today the appointment of Tara Eustace as Chief Opportunity and Sales Officer. As International Women's Day (IWD) approaches, this leadership appointment by the Chief Executive Officer, Ryan Rogers, honors Mary Kay Ash’s legacy of empowering women. A trailblazer and long-time Mary Kay executive, Eustace will lead the Global Opportunity and Sales organization with a core mission: to put the “Mary Kay Opportunity” at the center of all entrepreneurial business strategies. She will oversee all Mary Kay regions, leading the team of region presidents and general managers in over 40 markets around the world (Photo: Mary Kay Inc.).

A trailblazer and long-time Mary Kay executive, Eustace will lead the Global Opportunity and Sales organization with a core mission: to put the “Mary Kay Opportunity” at the center of all entrepreneurial business strategies. She will oversee all Mary Kay regions, leading the team of region presidents and general managers in over 40 markets around the world.

Eustace’s newly formed organization will focus on transforming the Independent Beauty Consultant (IBC) experience, elevating them as personal beauty advisors for Mary Kay’s product portfolio, brand, and opportunity. With the core mission at the forefront, Eustace will be inviting the next generation to join the entrepreneurial journey. To achieve the vision, she and her team will digitally empower all generations of IBCs with every opportunity to connect their businesses with consumers through digital upskilling, innovative digital tools, and e-commerce solutions across integrated platforms and channels.

Eustace will drive the streamlining of global sales operations, activating four strategic areas: global salesforce development and education, global salesforce experience, global salesforce insights & analytics, and global salesforce social commerce and communications. This includes a commitment to expanding Mary Kay’s footprint to empower women to pursue the dream of owning their small businesses wherever they are.

“Tara and her team are on a mission to ignite passion around the Mary Kay Opportunity, putting it at the forefront of everything we do,” said Ryan Rogers, Chief Executive Officer (CEO) of Mary Kay. “With her entrepreneurial and visionary mindset and a track record of breaking into new markets, Tara will be instrumental in shaping the future of the business for our Independent Beauty Consultants and their customers, leveraging technology and elevating our unparalleled experience to new heights in the beauty and direct-selling industries.”

Eustace has served in various leadership positions worldwide over the course of her more than thirty-year career. Her unwavering commitment to women’s entrepreneurship has contributed to reshaping the direct selling industry, touching the lives of millions of women, from personal growth to financial rewards and more. Eustace has led Mary Kay's growth in Europe and beyond, spearheading the most recent Mary Kay expansions into Hungary in 2023 and Kyrgyzstan in 2024.

“When Mary Kay Ash founded our company, she knew that no greater opportunity existed for women than the one we have to offer. I am energized to ignite innovation, empower our Independent Beauty Consultants to sell with confidence wherever they are, and connect the next generation to a vibrant, sustainable, and dynamic earning opportunity,” said Tara Eustace, Mary Kay’s Chief Opportunity and Sales Officer. “Every single one of our Independent Beauty Consultants is a small business owner who directly benefits from the sale of Mary Kay products. When local customers purchase Mary Kay products from Independent Beauty Consultants, they support a family. And when they support a family, they support a dream.”

Eustace holds a Bachelor of Arts degree in Russian Studies and International Relations from the University of Virginia, United States. She serves on the European Direct Selling Association’s (Seldia) CEO Council Board.

As International Women's Day (IWD) approaches, this leadership appointment by Ryan Rogers honors Mary Kay Ash’s legacy of empowering women. At Mary Kay, women make up 54% of the executive team, 63% of the global workforce, and 63% of the R&D team1.

Did you know:

  • Nearly 30% of sales force members who started a Mary Kay business over the past year are under the age of 352.
  • In 2023 and again in 2024, Mary Kay was named the #1 Direct Selling Brand of Skin Care & Color Cosmetics in the world by Euromonitor International3.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 40 markets. For over 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on X.

______________________________

1 Source: Women Representation and Leadership at Mary Kay (May 2024)

2 Source: Mary Kay Inc. 2024 U.S. data

3 “Source Euromonitor International Limited; Beauty and Personal Care 2024 Edition, value sales at RSP, 2023 data”

View source version on businesswire.com: https://www.businesswire.com/news/home/20250305002799/en/

Contacts

Mary Kay Inc. Corporate Communications
newsroom.marykay.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnewsroom.maryk
ay.com%2F&esheet=54219152&newsitemid=20250305002799&lan=en-US&anchor=newsroom.ma
rykay.com&index=9&md5=ee82fd29a7175444ab411f5f0d76bbdc
972.687.5332 or media@mkcorp.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release

Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release

The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th

Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release

Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor

Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release

Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not

BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye